Zongertinib 60 mg, 90 mg, 120mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 60 mg, 90 mg, 120mg
Reference Brands: Hernexeos (USA)
Category: Oncology Cancer Care
Zongertinib is an oral, small-molecule, irreversible tyrosine-kinase inhibitor that selectively targets the human epidermal growth factor receptor 2 (HER2/ERBB2) including certain activating mutations in the tyrosine-kinase domain. It is indicated for adult patients with unresectable or metastatic non-squamous NSCLC whose tumors harbor HER2 (ERBB2) tyrosine kinase domain activating mutations and who have previously received systemic therapy.
Zongertinib — third party manufacturing & bulk supply
Zongertinib 60 mg, 90 mg, 120mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Zongertinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Zongertinib →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Zongertinib is used to treat adults with unresectable or metastatic non-squamous non-small cell lung cancer (NSCLC) that has HER2 (ERBB2) tyrosine kinase domain mutations and who have received prior systemic therapy.
Zongertinib is a synthetic small-molecule tyrosine kinase inhibitor that selectively targets HER2 mutations to block cancer cell growth and division.
The trade name of Zongertinib is Hernexeos.
It is developed and manufactured by Boehringer Ingelheim Pharmaceuticals.
The generic name is Zongertinib.
The brand name is Hernexeos.
Zongertinib is manufactured in the United States by Boehringer Ingelheim.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
